The number of Australians living with depression that does not respond to medications could halve if a new WA study confirms that gene-based treatment for depression is more effective than current methods.
Working in conjunction with Meeting for Minds SYNERGIES, the GLAD project involves people with lived experience of mental illness (PLEX) as research partners. SYNERGIES is a new way of approaching research, bringing together researchers and PLEX, so that those who stand to gain the most from the benefits of the research are involved as respected contributors.
This study is a clinical trial conducted by The University of Western Australia’s Young Lives Matter Foundation into the use of pharmacogenomics (PG) to understand how a person’s genetic make-up influences how they metabolise medication). This trial will analyse whether PG-guided treatment is more effective than today’s widely adopted ‘trial and error’ approach.